Ketoprofen Gel vs Placebo in Low Back Pain

Sponsor
Akdeniz University (Other)
Overall Status
Unknown status
CT.gov ID
NCT02491879
Collaborator
Kocatepe University (Other), Celal Bayar University (Other)
100
1
2
7
14.2

Study Details

Study Description

Brief Summary

This study aimed to analyse the analgesic effect of ketoprofen gel in patients presented with mechanical low-back pain to the emergency department.

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

Mechanical low-back pain which warrants immediate pain relief is not an infrequent symptom for emergency department physicians to deal with. Parenteral analgesic is the most common drugs for the these patients in emergency department. However, pain killers in gel forms have not been studied sufficiently for ceasing the pain of these patients. This study aimed to analyse the analgesic effect of ketoprofen gel in patients presented with mechanical low-back pain to the emergency department.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Ketoprofen Gel vs Placebo in Patients Presented With Low-back Pain to Emergency Department: A Ranodmized Controlled Trial
Study Start Date :
Jun 1, 2015
Anticipated Primary Completion Date :
Jan 1, 2016
Anticipated Study Completion Date :
Jan 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Ketoprofen

Ketoprofen gel

Drug: Ketoprofen
2.5% Ketoprofen gel with a 2 g local use
Other Names:
  • Fastjel
  • Placebo Comparator: Placebo

    Placebo form of ketoprofen gel

    Other: Placebo
    Placebo gel with a 2 g local use
    Other Names:
  • normal saline
  • Outcome Measures

    Primary Outcome Measures

    1. Visual Analogue Scale [30 minutes]

      Pain reduce will be measured by visual analogue scale score at 30 minutes

    Secondary Outcome Measures

    1. Adverse outcome [30 minutes]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients over 18 and lower 65 years old

    • Patients presented with mechanical low-back pain

    Exclusion Criteria:
    • Pain more than 24 hours

    • Pain lower than with a pain score of 40 mm

    • Allergy to ketoprofen

    • Drug or alcohol addiction

    • pregnancy and breast feeding

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Pamukkale University Denizli Turkey

    Sponsors and Collaborators

    • Akdeniz University
    • Kocatepe University
    • Celal Bayar University

    Investigators

    • Study Chair: Mustafa Serinken, MD, Pamukkale University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Akdeniz University
    ClinicalTrials.gov Identifier:
    NCT02491879
    Other Study ID Numbers:
    • 24924
    First Posted:
    Jul 8, 2015
    Last Update Posted:
    Dec 3, 2015
    Last Verified:
    Dec 1, 2015
    Keywords provided by Akdeniz University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 3, 2015